Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 GVK Biosciences | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

GVK Biosciences

Dr. John Ellingboe has been appointed senior vice president of Discovery Chemistry for GVK Biosciences.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Dr. John Ellingboe has been appointed senior vice president of Discovery Chemistry for GVK Biosciences. Dr. Ellingboe will report to Mr. Manni Kantipudi, president of GVK Biosciences.

Prior to joining the company, Dr. Ellingboe worked with Wyeth Research and Pfizer for 25 years in senior scientific positions and has extensive medicinal chemistry and drug discovery experience. During his time at Wyeth, he established a core parallel synthesis group, a lead identification group, and an integrated medicinal chemistry group working in all phases of drug discovery. His responsibilities included the identification of leads and development candidates across multiple therapeutic areas and leading a department across several research sites. While at Wyeth, he also initiated and managed a large chemistry partnership with GVK BIO.

“I am pleased to welcome John on board. As senior vice president, Discovery Chemistry, John will lead the Medicinal Chemistry efforts of various Collaborative Research programs and will play a key role in guiding the company’s future Collaborative Research efforts,” said Sanjay Reddy, managing director, GVK Biosciences.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics